Blood Screening Market to Witness 10% CAGR to 2019

03 Nov, 2015, 07:30 ET from Sandler Research

PUNE, India, November 3, 2015 /PRNewswire/ --

The global market for blood screening is expected to post a modest market growth rate of approximately 10% during the period of 2014 and 2019 with high throughput sample analysis and increased workflow efficiency contributing towards the growth. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR.

Complete report on blood screening market spread across 74 pages, analyzing 4 major companies and supported with 44 data exhibits is now available at http://www.sandlerresearch.org/blood-screening-market-global-market-research-2015-2019.html.

The key players of the Global Blood Screening Market are Abbott Diagnostics, bioMérieux, Grifols and Roche Diagnostics. And the other prominent vendors in the market are Alere, Bio-Rad Laboratories, BD, Beckman Coulter, Cepheid, Diamedix, DiaSorin, Elitech, Eiken Chemical, Enzo Biochem, Fujirebio/Innogenetics, Hologic, Immunetics, Meridian Bioscience, Lab21, OraSure, Ortho Clinical Diagnostics, Qiagen, SeraCare, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, and Trinity Biotech.

This report analysts says the electronic record systems help medical experts gain access to blood samples and study their genotypic and phenotypic information. For instance, Illumina and Affymetrix provide high-throughput single-nucleotide polymorphism genotyping systems for accessing and storing genotyped data. Similarly, the barcoding system and robust encryption algorithm help in the rapid identification and increase the safety of samples.

According to the "Blood Screening Market - Global Market Research 2015 - 2019" report, blood safety is an important parameter taken into consideration after blood donation and before transfusion. The spread of infectious diseases through contaminated blood transfusions has mandated many regulatory bodies worldwide to implement stringent measures for blood screening. Order a copy of the research at http://www.sandlerresearch.org/purchase?rname=45530.

Competition between vendors in the developed countries is intense due to the availability of advanced blood screening assays and instruments. As many vendors compete with each other to gain superiority in this market, the launch of multiplexed assays by some prominent vendors will help them to gain traction in this market during the forecast period.

Further, the research states that the technical expertise of medical professionals using these devices is not up to par, which results in operational and technological issues. These factors, though, have increased the demand for skilled medical professionals; they impede the adoption of technologically advanced diagnostic devices.

Explore more reports on Medical Device at http://www.sandlerresearch.org/market-research/medical-device.

A relevant research titled Global Biologic Therapeutics Market 2015-2019 spread across 104 pages considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics) to calculate worldwide market size. Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors. Companies like Amgen, F. Hoffmann-La Roche, Novo Nordisk, Sanofi, AbbVie, AstraZeneca, Bavarian Nordic, Baxter International, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio Med Pvt., bioCSL, Biodel, Bristol-Myers Squibb, Diamyd Medical, DiaVacs, Dynavax Technologies, Eli Lilly, Generex Biotechnology, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen, JN International Medical, Kaketsuken, LG Life Sciences, Macrogenics, MannKind, Merck, Mitsubishi Tanabe Pharma, Nuron Biotech, Osiris Therapeutics, Pfizer, Protalix, Protein Sciences, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Tolerion, Vacunas Finlay, XOMA and Zydus Cadila  are mentioned in this research available at http://www.sandlerresearch.org/global-biologic-therapeutics-market-2015-2019.html .

About Us: 

SandlerResearch.org offers in-depth studies and research reports on a range of micro markets. Not limited to any one industry, SandlerResearch.org offers research studies on agriculture, energy and power, chemicals, environment, pharmaceuticals, biotechnology, water, advanced materials and much more.

Connect With Us on: 

Facebook: https://www.facebook.com/pages/Sandler-Research/524957830948790

Twitter: https://twitter.com/SandlerResearch

G+ / Google Plus: https://plus.google.com/+SandlerresearchOrg/posts

RSS/Feeds: http://www.sandlerresearch.org/feed/rss

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@sandlerresearch.org


SOURCE Sandler Research